Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.
Cancer|September 10, 2020
Curability of patients with lymph node metastases from extremity soft-tissue sarcomaGeorges Basile, Jean-Camille Mattei, Ibrahim Alshaygy, et al.
Clinical Colorectal Cancer|August 21, 2021
Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal CancerKanan Alshammari, Kyaw L Aung, Tong Zhang, et al.
Investigational New Drugs|October 17, 2014
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumorsNoelle K LoConte, Albiruni R A Razak, Percy Ivy, et al.
Investigational New Drugs|September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumorsSuzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
Nature Communications|February 6, 2024
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patientScott C Lien, Dalam Ly, S Y Cindy Yang, et al.
Investigational New Drugs|May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
Clinical Colorectal Cancer|July 3, 2024
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic CancerAlberto Hernando-Calvo, Ming Han, Olubukola Ayodele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.
Pageof 3